Stocks Explorer
Stocks
Sectors
Search
NewAmsterdam Pharma Company N.V.(NAMS) News
Profile
Chart
News
Analysis
NAMS price today
by TradingView
Date
Title
Aug 10
NewAmsterdam Pharma First Half 2023 Earnings: €0.92 loss per share (vs €1.50 profit in 1H 2022)
Aug 7
NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter 2023 Financial Highlights
‹ Prev
Page
of 2
Next ›